CT Follow-Up of the SImmetry Sacroiliac Joint Fusion System
NCT ID: NCT02425631
Last Updated: 2016-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2014-10-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study
NCT05628142
Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System
NCT05633888
Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT)
NCT03231046
Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter
NCT02349308
Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE
NCT02662881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SImmetry Sacroiliac Joint Fusion System
Minimally invasive surgery for implantation of the SImmetry System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is willing to comply with study procedures and provide informed consent.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zyga Technology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Ingham
Role: STUDY_DIRECTOR
Zyga
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL1097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.